CN105982925A - 一种治疗尿结石的中药组合物 - Google Patents

一种治疗尿结石的中药组合物 Download PDF

Info

Publication number
CN105982925A
CN105982925A CN201510042612.1A CN201510042612A CN105982925A CN 105982925 A CN105982925 A CN 105982925A CN 201510042612 A CN201510042612 A CN 201510042612A CN 105982925 A CN105982925 A CN 105982925A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
treating urinary
traditional chinese
urinary calculi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510042612.1A
Other languages
English (en)
Inventor
严富贵
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510042612.1A priority Critical patent/CN105982925A/zh
Publication of CN105982925A publication Critical patent/CN105982925A/zh
Pending legal-status Critical Current

Links

Abstract

本发明提供一种治疗尿结石的中药组合物,由海金沙和金钱草组成,临床有效率85%以上。

Description

一种治疗尿结石的中药组合物
技术领域
本发明涉及一种中药组合物,尤其是涉及一种治疗尿结石的中药组合物。
背景技术
现有技术治疗尿结石病症用药复杂,疗效不理想,而且有一定的毒副作用。
发明内容
本发明提供一种治疗尿结石的中药组合物,重量百分比为海金沙50%,金钱草50%,煎水当茶喝,每天各20克,连服半个月,即可从小便中排出结石。本发明用药简单,无毒副作用,临床有效率85%以上。
具体实施方式
实施例1、一种治疗尿结石的中药组合物,重量百分比为海金沙50%,金钱草50%,煎水当茶喝,每天各20克,连服半个月,即可从小便中排出结石。

Claims (1)

1.一种治疗尿结石的中药组合物,重量百分比为海金沙50%,金钱草50%,煎水当茶喝,每天各20克,连服半个月。
CN201510042612.1A 2015-01-28 2015-01-28 一种治疗尿结石的中药组合物 Pending CN105982925A (zh)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510042612.1A CN105982925A (zh) 2015-01-28 2015-01-28 一种治疗尿结石的中药组合物

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510042612.1A CN105982925A (zh) 2015-01-28 2015-01-28 一种治疗尿结石的中药组合物

Publications (1)

Publication Number Publication Date
CN105982925A true CN105982925A (zh) 2016-10-05

Family

ID=57034150

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510042612.1A Pending CN105982925A (zh) 2015-01-28 2015-01-28 一种治疗尿结石的中药组合物

Country Status (1)

Country Link
CN (1) CN105982925A (zh)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111228339A (zh) * 2020-03-26 2020-06-05 浙江大学 一种清热利湿的中药复方制剂
CN115475190A (zh) * 2022-10-17 2022-12-16 上海中医药大学附属龙华医院 一种治疗输尿管结石的中药组合

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111228339A (zh) * 2020-03-26 2020-06-05 浙江大学 一种清热利湿的中药复方制剂
CN115475190A (zh) * 2022-10-17 2022-12-16 上海中医药大学附属龙华医院 一种治疗输尿管结石的中药组合
CN115475190B (zh) * 2022-10-17 2023-06-06 上海中医药大学附属龙华医院 一种治疗输尿管结石的中药组合物

Similar Documents

Publication Publication Date Title
TN2012000143A1 (en) Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof
UA103915C2 (ru) Твердая лекарственная форма, которая содержит линаглиптин и ингибитор sglt2, и ее применение
TN2011000416A1 (en) Pharmaceutical composition comprising glucopyranosyl diphenylmethane derivatives, pharmaceutical dosage form thereof, process for their preparation and uses thereof for improved glycemic control in a patient
MX348817B (es) Metodos para tratar cancer y estados no neoplasicos.
MY173994A (en) Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
MY166557A (en) Quinazoline derivatives for the treatment of viral infections and further diseases
WO2013169864A3 (en) TETRAHYDRO[1,8]NAPHTHYRIDINE SULFONAMIDE AND RELATED COMPOUNDS FOR USE AS AGONISTS OF RORƴ AND THE TREATMENT OF DISEASE
TN2014000009A1 (en) Pharmaceutical compositions comprising rifaximin, processes for their preparation and their use in the treatment of vaginal infections
EP4279128A3 (en) Novel antibody binding to tfpi and composition comprising the same
WO2012125981A3 (en) Raf kinase inhibitors
CN105982925A (zh) 一种治疗尿结石的中药组合物
WO2011060253A3 (en) Methods of treating diseases, pharmaceutical compositions, and pharmaceutical dosage forms
MX350145B (es) Extracto proteolitico a partir de bromelaina para el tratamiento de trastornos del tejido conectivo.
WO2011019636A3 (en) Methods and compositions for the treatment of cancers and pathogenic infections
CA2863829A1 (en) Oral unit dosage forms and uses of same for the treatment of gaucher disease
CN105982948A (zh) 一种治疗脱肛的中药组合物
WO2009015447A3 (en) Polyacetal-carboxylic acids in the treatment of cancer and auto-immune disorders
WO2014086480A8 (en) Lignan compositions
NZ629475A (en) Pharmaceutical composition comprising benzyl alcohol for the treatment of migraines
WO2013093629A3 (en) Modular vaccines, methods and compositions related thereto
CN103007235A (zh) 一种治疗消化不良的中药
CN109620871A (zh) 治疗痢疾的药物配制方法
张义 Resection of thalamic gliomas via transcortico-ventriculo-choroidal approach
CN106176924A (zh) 一种治尿失禁的配方
CN106138255A (zh) 一种治疗泌尿结石的组合物中药

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20161005

WD01 Invention patent application deemed withdrawn after publication